PERRITT CAPITAL MANAGEMENT INC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 64 filers reported holding CARDLYTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
PERRITT CAPITAL MANAGEMENT INC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2020$280,000
+14.3%
4,000
-42.9%
0.21%
+4.5%
Q1 2020$245,000
-74.2%
7,000
-53.6%
0.20%
-56.0%
Q4 2019$949,000
+28.1%
15,100
-31.7%
0.46%
+44.9%
Q3 2019$741,000
+0.3%
22,100
-31.2%
0.31%
+121.1%
Q2 2019$739,000
+347.9%
32,100
+221.0%
0.14%
+129.0%
Q1 2019$165,00010,0000.06%
Other shareholders
CARDLYTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders